Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study

Aims Children with type 1 diabetes (T1D) risk and islet autoantibodies are recruited to a secondary prevention study. The aims were to determine metabolic control in relation to human leukocyte antigen (HLA) genetic risk and islet autoantibodies in prepubertal children. Methods In 47 healthy childre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatric diabetes Ročník 14; číslo 5; s. 341 - 349
Hlavní autoři: Andersson, Cecilia, Carlsson, Annelie, Cilio, Corrado, Cedervall, Elisabeth, Ivarsson, Sten-Anders, Jonsdottir, Berglind, Jönsson, Björn, Larsson, Karin, Neiderud, Jan, Lernmark, Åke, Elding Larsson, Helena
Médium: Journal Article
Jazyk:angličtina
Vydáno: Former Munksgaard John Wiley & Sons A/S 01.08.2013
Témata:
ISSN:1399-543X, 1399-5448, 1399-5448
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Aims Children with type 1 diabetes (T1D) risk and islet autoantibodies are recruited to a secondary prevention study. The aims were to determine metabolic control in relation to human leukocyte antigen (HLA) genetic risk and islet autoantibodies in prepubertal children. Methods In 47 healthy children with GADA and at least one additional islet autoantibody, intravenous glucose tolerance test (IvGTT) and oral glucose tolerance test (OGTT) were performed 8–65 d apart. Hemoglobin A1c, plasma glucose as well as serum insulin and C‐peptide were determined at fasting and during IvGTT and OGTT. Results All children aged median 5.1 (4.0–9.2) yr had autoantibodies to two to six of the beta‐cell antigens GAD65, insulin, IA‐2, and the three amino acid position 325 variants of the ZnT8 transporter. In total, 20/47 children showed impaired glucose metabolism. Decreased (≤30 μU/mL insulin) first‐phase insulin response (FPIR) was found in 14/20 children while 11/20 had impaired glucose tolerance in the OGTT. Five children had both impaired glucose tolerance and FPIR ≤30 μU/mL insulin. Number and levels of autoantibodies were not associated with glucose metabolism, except for an increased frequency (p = 0.03) and level (p = 0.01) of ZnT8QA in children with impaired glucose metabolism. Among the children with impaired glucose metabolism, 13/20 had HLA‐DQ2/8, compared to 9/27 of the children with normal glucose metabolism (p = 0.03). Conclusion Secondary prevention studies in children with islet autoantibodies are complicated by variability in baseline glucose metabolism. Evaluation of metabolic control with both IvGTT and OGTT is critical and should be taken into account before randomization. All currently available autoantibody tests should be analyzed, including ZnT8QA.
Bibliografie:Swedish Research Council - No. 14064
National Institutes of Health - No. DK26190
UMAS Fund
ark:/67375/WNG-JTDH4VRB-R
the Juvenile Diabetes Research Foundation - No. 17-2011-576
ArticleID:PEDI12023
the Skåne County Council for Research and Development
istex:E5D81344B08CF0B3EDDEEE1A762B72DE03934E6B
Swedish Childhood Diabetes Foundation
Swedish Diabetes Association
the Knut and Alice Wallenberg Foundation
See Appendix.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1399-543X
1399-5448
1399-5448
DOI:10.1111/pedi.12023